Earnings Call · Q1 FY2024·2024-05-02

Q1 24EPS 0.00%·Rev n/aQ4 23EPS +13.04%·Rev n/aQ3 23EPS +4.55%·Rev n/aQ2 23EPS -37.50%·Rev n/a⚠ consensus missing

LEXICON PHARMACEUTICALS, INC. LXRX

+2.4%1d on move date+1.1% vs SPY3d+4.1%5d+11.2%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LXRX calls or request research access.

More LXRX calls Browse calls Request research access